Award
National Cancer Institute 7K00CA284255-04
Investigating novel T cell autocrine pathways governing T cell fate
Recipient
University of California, San Diego
Award Amount
$44,050.00
Ceiling
$44,050.00
Awarded
May 18, 2026
Identifier
7K00CA284255-04
Research project funded by the National Cancer Institute to study novel pathways affecting CD8+ T cell survival in melanoma, aiming to enhance cancer immunotherapy outcomes.
Description
This project focuses on understanding mechanisms of T cell regulation and resistance to cancer immunotherapy, specifically investigating a pathway between CD8+ T cells and a suppressive protein that impacts T cell survival, with the goal of improving melanoma patient survival.